Related references
Note: Only part of the references are listed.UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Eric F. Pettersen et al.
PROTEIN SCIENCE (2021)
Structural and Functional Diversity of Resistance-Nodulation-Cell Division Transporters
Philip A. Klenotic et al.
CHEMICAL REVIEWS (2021)
Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis
Shipra Grover et al.
ACS INFECTIOUS DISEASES (2021)
The mycobacterial cell envelope - a moving target
Charles L. Dulberger et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus
Clement Raynaud et al.
ACS INFECTIOUS DISEASES (2020)
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
Giulia Degiacomi et al.
APPLIED SCIENCES-BASEL (2020)
Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1
Jasenko Zivanov et al.
IUCRJ (2020)
Antibiotics in the clinical pipeline in October 2019
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2020)
Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition
Ming Li et al.
ACS INFECTIOUS DISEASES (2020)
MmpL3 inhibitors as antituberculosis drugs
Min Shao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural Basis for the Inhibition of Mycobacterial MmpL3 by NITD-349 and SPIRO
Xiaolin Yang et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors
Matthew B. McNeil et al.
MSPHERE (2020)
Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction
Ali Punjani et al.
NATURE METHODS (2020)
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
Bing Zhang et al.
CELL (2019)
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
Wei Li et al.
ACS INFECTIOUS DISEASES (2019)
MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
Chih-Chia Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
1H-Benzo[d]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis
Malgorzata Korycka-Machala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance
John T. Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Illustrate: Software for Biomolecular Illustration
David S. Goodsell et al.
STRUCTURE (2019)
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis
Giovanna Poce et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
Dorothee Liebschner et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)
A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3
Christian Dupont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Identification of novel scaffolds targeting Mycobacterium tuberculosis
Michael Dal Molin et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection
Amit N. Pandya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis
Jasenko Zivanov et al.
IUCRJ (2019)
MolProbity: More and better reference data for improved all-atom structure validation
Christopher J. Williams et al.
PROTEIN SCIENCE (2018)
HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter
Huiqing Zheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
CAVER Analyst 2.0: analysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories
Adam Jurcik et al.
BIOINFORMATICS (2018)
RND transporters in the living world
Hiroshi Nikaido
RESEARCH IN MICROBIOLOGY (2018)
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
Wei Li et al.
FRONTIERS IN MICROBIOLOGY (2018)
Bacterial Factors That Predict Relapse after Tuberculosis Therapy
R. Colangeli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
Caroline Allix-Beguec et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
Valentin Trofimov et al.
SCIENTIFIC REPORTS (2018)
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
Mary A. De Groote et al.
FRONTIERS IN MICROBIOLOGY (2018)
Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
Annanya Shetty et al.
FRONTIERS IN MICROBIOLOGY (2018)
Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
Alan P. Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis
Matthew B. McNeil et al.
MICROBIOLOGY-SGM (2017)
The diverse family of MmpL transporters in mycobacteria: from regulation to antimicrobial developments
Albertus Viljoen et al.
MOLECULAR MICROBIOLOGY (2017)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
Michael A. DeJesus et al.
MBIO (2017)
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
Giulia Degiacomi et al.
SCIENTIFIC REPORTS (2017)
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members
Audrey Bernut et al.
MOLECULAR MICROBIOLOGY (2016)
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
Jozef Stec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Christian Dupont et al.
MOLECULAR MICROBIOLOGY (2016)
Mechanistic insight into mycobacterial MmpL protein function
R. Szekely et al.
MOLECULAR MICROBIOLOGY (2016)
ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules
Haim Ashkenazy et al.
NUCLEIC ACIDS RESEARCH (2016)
MmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteria
Christian Chalut
TUBERCULOSIS (2016)
Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosis
Marie H. Foss et al.
ACS INFECTIOUS DISEASES (2016)
Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis
Juan Manuel Belardinelli et al.
ACS INFECTIOUS DISEASES (2016)
Whole cell screen based identification of spiropiperidines with potent antitubercular properties
Subramanyam J. Tantry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
Timothy M. Walker et al.
LANCET INFECTIOUS DISEASES (2015)
The Phyre2 web portal for protein modeling, prediction and analysis
Lawrence A. Kelley et al.
NATURE PROTOCOLS (2015)
Recurrence due to Relapse or Reinfection With Mycobacterium tuberculosis: A Whole-Genome Sequencing Approach in a Large, Population-Based Cohort With a High HIV Infection Prevalence and Active Follow-up
Jose Afonso Guerra-Assuncao et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
MmpL3 a potential new target for development of novel anti-tuberculosis drugs
Geetha Vani Rayasam
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans
Inaki Comas et al.
NATURE GENETICS (2013)
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
Giovanna Poce et al.
PLOS ONE (2013)
Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
Modesto J. Remuinan et al.
PLOS ONE (2013)
Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
Thomas R. Ioerger et al.
PLOS ONE (2013)
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Srinivasa P. S. Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
Robert C. Goldman
TUBERCULOSIS (2013)
Indoleamides are active against drug-resistant Mycobacterium tuberculosis
Shichun Lun et al.
NATURE COMMUNICATIONS (2013)
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
Sarah A. Stanley et al.
ACS CHEMICAL BIOLOGY (2012)
MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
Cristian Varela et al.
CHEMISTRY & BIOLOGY (2012)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E. Grzegorzewicz et al.
NATURE CHEMICAL BIOLOGY (2012)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran
Ali Akbar Velayati et al.
CHEST (2009)
Drug therapy of experimental tuberculosis (TB): Improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs
Boris V. Nikonenko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A scalable, GFP-based pipeline for membrane protein overexpression screening and purification
D Drew et al.
PROTEIN SCIENCE (2005)
Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance
P Domenech et al.
INFECTION AND IMMUNITY (2005)
Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry
Y Fujita et al.
MICROBIOLOGY-SGM (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Green fluorescent protein as an indicator to monitor membrane protein overexpression in Escherichia coli
DE Drew et al.
FEBS LETTERS (2001)
TEXtopo:: shaded membrane protein topology plots in LATEX2ε
E Beitz
BIOINFORMATICS (2000)
TEXshade:: shading and labeling of multiple sequence alignments using LATEX 2ε
E Beitz
BIOINFORMATICS (2000)
Share Paper
